# Goldbell Group's Biotech Investments: 11 Startups in Its Portfolio (2026)

> The 11 Biotech startups Goldbell Group has backed, by stage: $2.0B raised between them. From the rounds we track; updated nightly.

Source: https://millionrounds.com/portfolio-maps/polaris-biotech-portfolio (Millionrounds; every figure on the page links to its filing or article)

## Series C and later

6

- [Metacrine](https://millionrounds.com/company/metacrine)
- [*SB* SQZ Biotechnologies](https://millionrounds.com/company/sqz-biotechnologies)
- [Visterra](https://millionrounds.com/company/visterra)
- [Neuronetics](https://millionrounds.com/company/neuronetics)
- [Faraday Pharmaceuticals](https://millionrounds.com/company/faraday-pharmaceuticals)
- [Arsanis](https://millionrounds.com/company/arsanis)

## Series B

3

- [Gossamer Bio](https://millionrounds.com/company/gossamer-bio)
- [Kallyope](https://millionrounds.com/company/kallyope)
- [Lyra Therapeutics](https://millionrounds.com/company/lyra-therapeutics)

## Stage not reported

2

- [Freenome](https://millionrounds.com/company/freenome)
- [Frequency Therapeutics](https://millionrounds.com/company/frequency-therapeutics)

## Segment by segment

### Series C and later

6 startups · $693M raised

- [**Metacrine**](https://millionrounds.com/company/metacrine) Metacrine is a clinical-stage bio pharmaceutical company focused on building an innovative pipeline of best-in-class drugs. United States $173M
- [*SB* **SQZ Biotechnologies**](https://millionrounds.com/company/sqz-biotechnologies) United States $137M
- [**Visterra**](https://millionrounds.com/company/visterra) Visterra researches on and develops therapeutic and diagnostic products for the treatment of infectious diseases. United States $120M
- [**Neuronetics**](https://millionrounds.com/company/neuronetics) Neuronetics is a medical device company that develops non-invasive therapies for psychiatric and neurological disorders. United States $110M
- [**Faraday Pharmaceuticals**](https://millionrounds.com/company/faraday-pharmaceuticals) Faraday Pharmaceuticals is an early-stage therapeutics company focused on developing novel therapies to treat ischemia-reperfusion injury. United States $78M
- [**Arsanis**](https://millionrounds.com/company/arsanis) Arsanis is a biopharmaceutical company developing infectious disease treatments based on bacterial protein and carbohydrate antigens. Austria $76M

### Series B

3 startups · $692M raised

- [**Gossamer Bio**](https://millionrounds.com/company/gossamer-bio) Gossamer Bio is a biopharmaceutical company focused on the discovery and development of novel and differentiated therapeutic products. United States $567M
- [**Kallyope**](https://millionrounds.com/company/kallyope) Kallyope uses the science of gut-brain biology to create medicines that transform human health. United States $95M
- [**Lyra Therapeutics**](https://millionrounds.com/company/lyra-therapeutics) Lyra Therapeutics is a clinical-stage company developing medicines to treat ear, nose, and throat diseases. United States $30M

### Stage not reported

2 startups · $627M raised

- [**Freenome**](https://millionrounds.com/company/freenome) Freenome is a biotechnology company with a comprehensive multiomics platform for cancer detection using a routine blood draw. United States $553M
- [**Frequency Therapeutics**](https://millionrounds.com/company/frequency-therapeutics) Frequency Therapeutics develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue. United States $74M

**How this map is made.** Every startup here works in Biotech and has raised money in a round we track that names Goldbell Group as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.

## More portfolio maps

[All portfolios](https://millionrounds.com/portfolio-maps)

[Co-investors **Who invests with Goldbell Group** 20 co-investors](https://millionrounds.com/portfolio-maps/polaris-co-investors)[Sector portfolio **Y Combinator's AI portfolio** 1,143 startups · $44B](https://millionrounds.com/portfolio-maps/y-combinator-ai-portfolio)[Sector portfolio **Y Combinator's Fintech portfolio** 338 startups · $24B](https://millionrounds.com/portfolio-maps/y-combinator-fintech-portfolio)[Sector portfolio **Techstars' AI portfolio** 336 startups · $4.9B](https://millionrounds.com/portfolio-maps/techstars-ai-portfolio)[Sector portfolio **Alumni Ventures' AI portfolio** 302 startups · $36B](https://millionrounds.com/portfolio-maps/us-strategic-tech-fund-an-alumni-ventures-fund-ai-portfolio)[Sector portfolio **Andreessen Horowitz's AI portfolio** 259 startups · $426B](https://millionrounds.com/portfolio-maps/andreessen-horowitz-ai-portfolio)

## Raising from investors like Goldbell Group?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.

[Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)